Pennington, NJ, United States of America

James A Johnson

This inventor holds 49 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 20 EPO patents, primarily in Pharmaceutical Inhibitors. Top assignees: Bristol-Myers Squibb Compnay, Rosemount Inc.. Active years: 2001-2026.

USPTO Granted Patents = 49 (Patent Applications = 9)

% Patents Active = 95.9

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 20 (Patent Applications = 20)

Average Co-Inventor Count = 3.9

ph-index = 9

Forward Citations = 252(Granted Patents)

Location History:

Lawrenceville, NJ (US) (2001 - 2013)
Pennington, NJ (US) (2010 - 2021)
Savage, MN (US) (2003 - 2024)

Company Filing History:

36 out of 3,735

Bristol-Myers Squibb Compnay

Years Active: 2001-2026

Loading Chart...

Areas of Expertise:

Potassium Ion Channels

Endothelial Lipase

CETP Inhibitors

APJ Agonists

Quinazolines

Heterocyclic Compounds

Pyrazolone

Pyrrolidinone Derivatives

Industrial Field Devices

Battery Assembly

Macrocyclic Inhibitors

Epothilone Derivatives

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12577206 - Pyrazolone formyl peptide 2 receptor agonists (2026-03-17),

2. 12425062 - Load adapter module for wireless discrete input/output field device (2025-09-23),

3. 12281108 - Pyrrolidinone derivatives as formyl peptide 2 receptor agonists (2025-04-21),

4. 11008306 - Quinazolines as potassium ion channel inhibitors (2021-05-18),

5. 10676460 - Quinazolines as potassium ion channel inhibitors (2020-06-09),

6. 10590113 - 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists (2020-03-17),

7. 10392347 - 2,4-dihydroxy-nicotinamides as APJ agonists (2019-08-27),

8. 10336739 - 4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists (2019-07-02),

9. 10173991 - Sulfone amide linked benzothiazole inhibitors of endothelial lipase (2019-01-08),

10. 10106528 - 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists (2018-10-23),

11. 10011594 - 4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists (2018-07-03),

12. 9822096 - Quinazolines as potassium ion channel inhibitors (2017-11-21),

13. 9483039 - Wireless field device having discrete input/output (2016-11-01),

14. 9458114 - Quinazolines as potassium ion channel inhibitors (2016-10-04),

15. 9391568 - Process device with light change triggered display (2016-07-12),

Title: The Innovative Journey of James A Johnson

Introduction: James A Johnson, a distinguished inventor hailing from Pennington, NJ, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Johnson's latest patents include a cutting-edge software application for data encryption and a revolutionary design for a solar-powered heating system.

Career Highlights: With a career spanning over two decades, Johnson has established himself as a visionary inventor with a keen eye for technological advancements. His work has been pivotal in shaping the landscape of modern innovation.

Collaborations: Throughout his career, Johnson has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work in multidisciplinary teams has led to the successful development of several groundbreaking technologies.

Conclusion: James A Johnson's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true pioneer in the world of inventions. His contributions continue to inspire the next generation of inventors and shape the future of technological advancements.